Copyright (c) 2010 Yahoo! Inc. All rights reserved.http://finance.yahoo.com/q/h?s=gernLatest Financial News for Geron Corporationen-usTue, 5 Jan 2010 16:20:13 Etc/GMThttp://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gifhttp://finance.yahoo.com14417http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/100105/us_geron_study.html?.v=1Biotechnology company Geron Corp. said Tuesday its developing stem-cell technology inhibited tumor activity and reduced tumor size in a laboratory study focusing on the most common form of brain cancer.yahoo_finance/2156864430Tue, 5 Jan 2010 16:20:13 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/100105/20100105005748.html?.v=1MENLO PARK, Calif.----Geron Corporation today announced the publication of preclinical data demonstrating that its telomerase inhibitor drug, imetelstat , inhibited telomerase activity and reduced tumor size in xenograft models of glioblastoma, and inhibited the activity of glioblastoma stem cells in culture.yahoo_finance/2581194875Tue, 5 Jan 2010 12:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12q6c5lno/*http%3A//www.fool.com/investing/high-growth/2009/12/22/pfizer-swings-for-the-fences.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/1462500359Tue, 22 Dec 2009 18:38:41 Etc/GMThttp://us.rd.yahoo.com/finance/external/reuters/rss/SIG=118cks9u6/*http%3A//www.reuters.com/legacyArticle?duid=mtfh56713_2009-12-21_15-44-08_sge5bk0de_newsml&rpc=44&type=marketsNewsyahoo_finance/830897189Mon, 21 Dec 2009 15:44:08 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12uv4f7ja/*http%3A//www.thestreet.com/_yahoo/story/10647632/1/biotech-stock-mailbag-year-in-review.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/537529219Fri, 18 Dec 2009 12:00:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/e/091215/gern8-k.htmlyahoo_finance/2456072438Tue, 15 Dec 2009 22:15:59 Etc/GMThttp://us.rd.yahoo.com/finance/external/FoxBusiness.com/rss/SIG=12b4u4tof/*http%3A//www.foxbusiness.com/story/markets/early-market-movers-xto-geron/yahoo_finance/1035420150Mon, 14 Dec 2009 14:03:56 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091214/20091214005358.html?.v=1MENLO PARK, Calif.----Geron Corporation today announced that the U.S. Patent and Trademark Office, Board of Patent Appeals and Interferences, has granted Geron’s request to declare an interference between a patent application owned by Geron and U.S.yahoo_finance/4014071808Mon, 14 Dec 2009 12:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/zacks/091211/28211.html?.v=1Geron recently presented encouraging interim data on its pipeline candidate, GRNVAC1.yahoo_finance/165520038Fri, 11 Dec 2009 14:24:36 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=12f2vvvp9/*http%3A//www.fool.com/investing/general/2009/12/09/rising-from-the-ashes.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/2282362022Wed, 9 Dec 2009 20:44:14 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091208/us_geron_study.html?.v=2Biotechnology company Geron Corp. said Tuesday its developing cancer treatment GRNVAC1 met safety and tolerability goals in a midstage study.yahoo_finance/78982688Tue, 8 Dec 2009 23:06:31 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/indie/091208/2615_id.html?.v=1Geron jumped on Tuesday following positive interim data in leukemia study.yahoo_finance/2028379919Tue, 8 Dec 2009 14:36:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12vi3d061/*http%3A//www.thestreet.com/_yahoo/story/10640723/1/early-volume-plays-quadramed-ja-solar.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/85776230Tue, 8 Dec 2009 14:18:03 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/bw/091208/20091208005516.html?.v=1MENLO PARK, Calif.----Geron Corporation today announced the presentation of interim data from its phase II trial of GRNVAC1, an autologous dendritic cell vaccine targeting telomerase, in patients with acute myelogenous leukemia at the 51st Annual Meeting of the American Society of Hematology in New Orleans, Louisiana.yahoo_finance/3363676906Tue, 8 Dec 2009 12:30:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/wsj/rss/SIG=11rfbotnh/*http%3A//online.wsj.com/article/SB125977557654473117.html?ru=yahoo&mod=yahoo_hsyahoo_finance/3037507252Thu, 3 Dec 2009 02:56:01 Etc/GMThttp://us.rd.yahoo.com/finance/external/pssa/rss/SIG=122rfmao3/*http%3A//seekingalpha.com/article/176237-wednesday-options-recap?source=yahooyahoo_finance/643320587Wed, 2 Dec 2009 21:13:15 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/091202/us_stem_cells_stocks.html?.v=4Shares of companies developing stem cell therapies surged Wednesday on news that the federal government has cleared 13 new stem cell lines for testing, bringing to a close nearly a decade of restrictions.yahoo_finance/3792135594Wed, 2 Dec 2009 20:39:03 Etc/GMThttp://us.rd.yahoo.com/finance/external/tsmfe/rss/SIG=12voocgig/*http%3A//www.thestreet.com/_yahoo/story/10637120/1/geron-stemcells-late-day-volume-plays.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NAyahoo_finance/1097052206Wed, 2 Dec 2009 20:04:05 Etc/GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/indie/091202/2601_id.html?.v=1A major breakthrough for stem cell research sent stocks soaring on Wednesday.yahoo_finance/2262022244Wed, 2 Dec 2009 19:23:00 Etc/GMThttp://us.rd.yahoo.com/finance/external/mfool/rss/SIG=139set9op/*http%3A//www.fool.com/investing/general/2009/11/27/4-star-stocks-poised-to-pop-cytori-therapeutics.aspx?source=eptyholnk303100&logvisit=y&npu=yyahoo_finance/3114632327Fri, 27 Nov 2009 14:49:13 Etc/GMT